Stock Groups

Israel stocks lower at close of trade; TA 35 down 0.74% -Breaking

by Mike Robinson

[ad_1]

© Reuters Israel stocks lower at close of trade; TA 35 down 0.74%

Investing.com – Israel stocks were lower after the close on Sunday, as losses in the , and sectors led shares lower.

The closing in Tel Aviv saw the decline of 0.74%.

They were the top performers at the session Energix (TASE): The stock rose by 2.87%, or 37 points, to close at 1325. Perrigo (+2.86%) added 350 points to reach 12600, while Teva Pharmaceutical Industry Ltd (TASE), was up 2.5% or 67 to 2747 by late trade.

Nice Ltd (TASE) was the worst performer of the session, falling 3.25% or 2890 point to close at 86110. Nova (TASE) fell 2.59%, or 1090 point to close at 40960. Liveperson (TASE) dropped 2.34% or 244 points to 10020.

The Tel Aviv Stock Exchange saw falling stocks surpass advancing stock by 312 to 1,188, and 27, respectively.

Liveperson shares fell 52 weeks ago to their lowest point; they lost 2.34%, or 240 to 10020.

Oil for February delivery fell 0.57 percent or 0.57 to $78.89/barrel. Brent oil fell 0.21 percent to $81.78 per barrel in commodities trading. The February Gold Futures contract traded at $1796.25 an ounce.

The USD/ILS exchange rate was up 0.5% at 3.1079 while the EUR/ILS exchange rate rose 0.67% at 3.5309.

At 95.735, the US Dollar Index Futures fell 0.61%.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]